Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis

F Kang, S Wang, F Tian, M Zhao, M Zhang… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The objectives of this study were to compare the diagnostic potential of 68Ga-Alfatide II
with18F-FDG in differentiating between non–small cell lung cancer patients (NSCLC) and …

[HTML][HTML] Comparing the Differential Diagnostic Values of 18F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients

X Du, Y Zhang, L Chen, B Mi, Q You, Y Xu… - Contrast Media & …, 2018 - hindawi.com
Purpose. To compare the differential diagnostic values of 18 F-Alfatide II PET/CT between
tuberculosis and lung cancer patients and in patients with sarcoidosis and common …

A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients

S Gao, H Wu, W Li, S Zhao, X Teng, H Lu, X Hu… - European journal of …, 2015 - Springer
Purpose Angiogenesis is an essential step in tumour development and metastasis. Integrin
αvβ3 plays a major role in angiogenesis, tumour growth and progression. A new tracer, 18 F …

[HTML][HTML] A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer

Y Zhou, S Gao, Y Huang, J Zheng, Y Dong, B Zhang… - Scientific Reports, 2017 - nature.com
Angiogenesis plays a key role in tumor development and αvβ3 integrin are overexpressed
on the endothelial cell surface of newly forming vessels. 18F-Alfatide has favorable …

Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging

F Kang, Z Wang, G Li, S Wang, D Liu, M Zhang… - European journal of …, 2017 - Springer
Purpose Integrin α v β 3 is the therapeutic target of the anti-angiogenic drug cilengitide. The
objective of this study was to compare α v β 3 levels in non-small cell lung cancer (NSCLC) …

Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer

C Can, F Kepenek, H Kömek… - Nuclear Medicine …, 2022 - journals.lww.com
Aim In this study, we aimed to compare the diagnostic accuracy of 18 F− fluorodeoxyglucose
(18 F-FDG) and Gallium-68 labeled fibroblast activator protein inhibitor (68 Ga-FAPI)-04 …

[HTML][HTML] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the evaluation of patients with newly diagnosed non-small cell lung cancer

J Wu, H Deng, H Zhong, T Wang, Z Rao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Purpose: Several studies have demonstrated that 68Ga-FAPI PET/CT shows high
intratumoral tracer uptake and low normal tissue uptake, allowing for excellent visualization …

Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysis

G Shen, H Ma, F Pang, P Ren, A Kuang - Acta Radiologica, 2018 - journals.sagepub.com
Background Positron emission tomography (PET) imaging using the radiotracers 18F-
fluorodeoxyglucose (FDG) or 18F-fluorothymidine (FLT) has been proposed as imaging …

18F-Alfatide II for the evaluation of axillary lymph nodes in breast cancer patients: comparison with 18F-FDG

J Wu, J Tian, Y Zhang, H Ji, J Sun, X Wang… - European Journal of …, 2022 - Springer
Abstract Purpose 18F-Alfatide II has been translated into clinical use and been proven to
have good performance in identifying breast cancer. In this study, we investigated 18F …

Evaluation of thoracic tumors with 18F‐FMT and 18F‐FDG PET‐CT: A clinicopathological study

K Kaira, N Oriuchi, K Shimizu, T Ishikita… - … Journal of Cancer, 2009 - Wiley Online Library
Abstract L‐[3‐18F]‐α‐methyltyrosine (18F‐FMT) is an aminoacid tracer for positron emission
tomography (PET). The aim of this study was to determine whether PET‐CT with 18F‐FMT …